Animal Hoarding: a systematic review.

Objective: Animal hoarding is a special manifestation of Hoarding Disorder, characterized by the accumulation of animals and failure to provide them with minimal care. The main objective of this systematic review is to evaluate the characteristics of animal hoarding with a focus on the profile of affected individuals and accumulation behavior features.

Methods: A systematic search of the literature using the electronic databases MEDLINE, SCOPUS and LILACS was conducted until October 2022.

Cognitive impairment in hoarding disorder: a systematic review.

Objective: In the present study, we aimed to perform a systematic review evaluating the cognitive performance of patients with hoarding disorder (HD) compared with controls. We hypothesized that HD patients would present greater cognitive impairment than controls.

Methods: A systematic search of the literature using the electronic databases MEDLINE, SCOPUS, and LILACS was conducted on May 2020, with no date limit.

Higher rate of major depression among blood donor candidates infected with human t-cell lymphotropic virus type 1.

Objective: Viral infections have been previously associated with psychiatric disorders. This work aimed to study the relationship between the human T-cell lymphotropic virus type 1 (HTLV-1) and depression.

Method: A case-control study with prevalent cases was conducted from April 2004 to June 2005.

Is insomnia a marker for psychiatric disorders in general hospitals?

Background And Purpose: The aim was to evaluate the relationship between insomnia and psychiatric disorders in general hospital inpatients.

Patients And Methods: Information about insomnia was collected using a structured and codified questionnaire adapted from a previously validated one in Brazil. For Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) psychiatric diagnosis, the Portuguese version of the International Neuropsychiatric Interview (MINI) was used.

Prevalence of excessive daytime sleepiness and associated factors in a Brazilian community: the Bambuí study.

Background And Purpose: Population-based studies of excessive daytime sleepiness (EDS) among adults residing in communities in developing countries are scarce. The objectives of the present study were to determine the prevalence of EDS in a Brazilian town with 15,000 inhabitants (Bambuí, MG), and the socio-demographic characteristics associated with it.

Patients And Methods: In this study, 87.

Prevalence of insomnia and associated socio-demographic factors in a Brazilian community: the Bambuí study.

Background: Population-based studies of insomnia among adults residing in communities in developing countries are rare. The objectives of this population-based study were to determine the prevalence and factors associated with insomnia among adults (18 years and over) living in a Brazilian town with 15,000 inhabitants (Bambuí MG) and to determine how the use of different definitions of insomnia affect its prevalence.

Methods: A total of 87.

Prevalence of sleep complaints and associated factors in community-dwelling older people in Brazil: the Bambuí Health and Ageing Study (BHAS).

Background: Population-based studies of insomnia among older people residing in communities in developing countries are rare. The objectives of this population-based study were to determine the prevalence and factors associated with insomnia among older adults (60 years and over) living in a Brazilian town with 15,000 inhabitants (Bambuí MG).

Methods: All 1742 residents in this age group were selected for a structured interview and blood tests.

Lamotrigine augmentation in unipolar depression.

A significant number of patients with unipolar depression fail to achieve remission after one or a series of antidepressants. We present the results of a retrospective chart review of the efficacy and tolerability of lamotrigine as an augmentation drug in treatment-resistant unipolar depression. A previous absence of a response was defined as the clinically significant presence of depressive symptomatology after 6 weeks of treatment with an antidepressant, with at least 3 weeks at the maximum dose tolerated by the patient.